Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline PK in Hepatic Impairment
NCT02135302Phase 1Completed
- Sponsor
- Tetraphase Therapeutics
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of eravacycline in bacterial infection (2 arms), sponsored by Tetraphase Therapeutics. Primary endpoint: Pharmacokinetic profile of eravacycline at 1 year. Started Oct 2013; status: completed.
02
Drugs
eravacycline
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02135302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135302.